---
figid: PMC5409837__nihms855010f8
figtitle: High-Throughput Screening of Tyrosine Kinase Inhibitor Cardiotoxicity with
  Human Induced Pluripotent Stem Cells
organisms:
- Armoracia rusticana
- Diaporthe sclerotioides
- Triticum aestivum
- Matthiola incana
- Homo sapiens
- Mus musculus
- Danio rerio
- Coxsackievirus B3
- archaeon RC26
- NA
organisms_ner:
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC5409837
filename: nihms855010f8.jpg
figlink: /pmc/articles/PMC5409837/figure/F8/
number: F8
caption: (A) In hiPSC-CMs, receptor tyrosine kinases VEGFR2, PDGFRα, INSR, and IGF1R
  are upstream of pro-survival signaling pathways. (B) Our results suggest that VEGFR2/PDGFR-inhibiting
  TKIs upregulate INSR and IGF1R signaling (phosphorylation) to compensate for the
  loss of VEGFR/PDGFR signaling (phosphorylation). This compensatory effect can augment
  cardiomyocyte survival during TKI treatment via introduction of exogenous insulin
  and IGF1 ligands. We observed an increase in the downstream gene expression of non-canonical
  VEGF-binding receptors and VEGFR pathway members, presumably to compensate for VEGFR2/PDGFR-inhibiting
  TKI-induced loss in upstream VEGFR signaling (phosphorylation).
papertitle: High-Throughput Screening of Tyrosine Kinase Inhibitor Cardiotoxicity
  with Human Induced Pluripotent Stem Cells.
reftext: Arun Sharma, et al. Sci Transl Med. ;9(377):eaaf2584.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9222823
figid_alias: PMC5409837__F8
figtype: Figure
redirect_from: /figures/PMC5409837__F8
ndex: 4d379b3a-df0d-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5409837__nihms855010f8.html
  '@type': Dataset
  description: (A) In hiPSC-CMs, receptor tyrosine kinases VEGFR2, PDGFRα, INSR, and
    IGF1R are upstream of pro-survival signaling pathways. (B) Our results suggest
    that VEGFR2/PDGFR-inhibiting TKIs upregulate INSR and IGF1R signaling (phosphorylation)
    to compensate for the loss of VEGFR/PDGFR signaling (phosphorylation). This compensatory
    effect can augment cardiomyocyte survival during TKI treatment via introduction
    of exogenous insulin and IGF1 ligands. We observed an increase in the downstream
    gene expression of non-canonical VEGF-binding receptors and VEGFR pathway members,
    presumably to compensate for VEGFR2/PDGFR-inhibiting TKI-induced loss in upstream
    VEGFR signaling (phosphorylation).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Vegfa
  - Igf1
  - Insr
  - Pdgfra
  - Igf1r
  - Kdr
  - Akt1
  - Pik3r1
  - Pnisr
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - IGF1
  - INSR
  - IGF1R
  - INSRR
  - PDGFRA
  - KDR
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - Pvf1
  - Pvf2
  - Pvf3
  - Pvr
  - InR
  - Akt
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Cancer
---
